Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis Patients

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Multiple Sclerosis
Interventions
DEVICE

Myo Armband (MYO,Thalamic Labs Inc, Kitchener, ON, Canada)

"MYO armband is a commercialized, gesture control device containing Height Medical Grade Stainless Steel EMG sensors, and an inertial measurement unit (IMU) consisting of a three-axis gyroscope and a, three-axis accelerometer, three-axis magnetometer. MY0 motion data (EMG and IMU) will be recorded during standard motor/neurological evaluation.~The clinical assessment will include standard motor neurological evaluation : EDSS and FS, walking status, foot tapping test, Heel-knee test, finger tapping test, Finger to nose test, Romberg test, timed 25 foot walk test, nine holes peg test. This clinical assessment will be done at the inclusion visit (V1) and at the follow-up visit at one year (V2)."

Trial Locations (1)

44093

CHU de Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03369171 - Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter